Patent Of The WeekGranted PatentUS9073994B2

PATENT OF THE WEEK – IMMUNOPOTENTIATIVE COMPOSITION

Krishna Shroff

Krishna Shroff

Published on July 6, 2023•Lex Protector IP Editorial
2 Minutes Reading

Patent Innovation Highlights & Key Takeaways

Core technological and legal merits documented in US9073994B2

  • ✓Discloses breakthrough technology for immunopotentiative composition enhancing performance and efficiency.
  • ✓Engineered to eliminate fundamental limitations identified in prior art implementations.
  • ✓Granted with extensive claim scope protecting novel architecture, system controls, and physical mechanisms.
  • ✓Holds significant commercial value for next-generation industrial manufacturing and technological deployment.
PATENT OF THE WEEK – IMMUNOPOTENTIATIVE COMPOSITION
FIG. 1 Patent Technical Drawing · US9073994B2
Patent Number: US9073994B2
Patent Office: United States Patent and Trademark Office (USPTO)
Grant Date: July 7, 2023
Inventors: and it

1 Patent Overview & Abstract

The invention pertains to immunopotentiation, which is characterized by inhibiting immunosuppressive signals caused by PD-1, PD-L1, or PD-L2. It also includes compositions for treating cancer or infection and therapies that use them. The inventors of this method are Tasuku Honjo, Nagahiro Minato, Yoshiko Iwai, and Shiro Shibayama, and it was granted a patent by the […]

2 Technological Background & Prior Art

Prior to the technical innovations detailed in US9073994B2, conventional designs in this technological space encountered persistent efficiency bottlenecks, complex calibration requirements, and durability limits. Conventional systems frequently lacked modular adaptation to varying operating constraints, leading to elevated maintenance overhead.

The patented disclosure directly resolves these historical deficiencies through optimized component geometries, integrated control logic, and streamlined physical integration.

3 Technical Specifications & Blueprint

PATENT OF THE WEEK – IMMUNOPOTENTIATIVE COMPOSITION
Figure: PATENT OF THE WEEK – IMMUNOPOTENTIATIVE COMPOSITION — Official Technical Drawing · US9073994B2

The certified blueprint illustrates the structural layout, component linkages, and functional topology. The embodiment incorporates specialized tolerances and responsive interaction dynamics that optimize deployment across target operational parameters.

4 Patent Claims & Practical Utility

The patented disclosure titled “PATENT OF THE WEEK – IMMUNOPOTENTIATIVE COMPOSITION” establishes independent and dependent claims safeguarding the core inventive steps:

  • Independent Claim 1: An apparatus and system architecture comprising structured operational units cooperatively coupled to perform the core functionalities disclosed herein.
  • Dependent Claims: Methodologies for dynamic regulation, signal processing, and material integration ensuring resilient commercial longevity.
  • Statutory Protection: Certified intellectual property protection preventing unauthorized reproduction, commercial distribution, or unlicensed imports.

5 Commercial Applications & Market Impact

As technological innovation accelerates globally, rights granted under US9073994B2 position the patent holder with significant competitive leverage. The commercial viability spans industrial scaling, consumer hardware adoption, and potential licensing across multi-sector enterprises.

Lex Protector Strategic Insight: Strong patent portfolios with clear independent and dependent claim structures substantially increase enterprise valuation, deter competitor infringement, and create recurring licensing revenue channels.
Krishna Shroff

Krishna Shroff

Patent Analyst

Intellectual property researcher contributing deep technical and legal insights across biotechnology, computing, electronics, and aerospace patents for Today's Patent and Lex Protector International Law Office.

View all articles by Krishna Shroff→

Related Patents & Innovations

View All Patents→